{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Farthritis-life-podcast.simplecast.com%2Fepisodes%2Fdr-singh-nGltGQRO","width":444,"version":"1.0","type":"rich","title":"Exploring the Intersection of Cancer and Rheumatoid Arthritis, with Dr. Singh","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/0c125f88-10fc-4966-9b68-4931832769e4/234c4b95-626e-4cf5-a8b5-af3287aad4f9/episode_216_dr_singh_square_1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/c7af8146-f4c8-41bf-bcee-9cc7d72d24e0\" height=\"200\" width=\"100%\" title=\"Exploring the Intersection of Cancer and Rheumatoid Arthritis, with Dr. Singh\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"What happens when cancer care, arthritis care, and aging intersect? \nIn this episode, Cheryl talks with rheumatologist Dr. Namrata Singh from the University of Washington about what people with inflammatory arthritis should know about cancer risk, arthritis treatments, and emerging medical advances. Dr. Singh explains the latest research on biologic medications and cancer risk, discusses how some cancer treatments can trigger inflammatory arthritis, and highlights the importance of collaboration between rheumatologists and oncologists. \n"}